Biomarin Pharmaceutical Inc (BMRN) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Biomarin Pharmaceutical Inc  (NASDAQ: BMRN)


Biomarin Pharmaceutical Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Biomarin Pharmaceutical Inc's ROI in the second quarter of 2026?
Biomarin Pharmaceutical Inc achieved a return on average invested assets (ROI) of 0.91 % in its second quarter of 2026, this is above BMRN's average return on investment of -0.5%.
Biomarin Pharmaceutical Incs investments during the 12 months ending in the second quarter of 2026 are valued at $7 billion

ROI decreased relative to the period ending Mar 31 2026, due to the decline in net income.

Within the Healthcare sector 180 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1671 to 1762.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 23.82 % 12.72 % 10.86 % 12.32 % 12 %
Y / Y Net Income Change TTM -88.9 % -48.7 % 3.17 % 144.04 % 513.25 %
Investment (TTM) in Millions 10,508 7,798 6,835 6,816 6,772
Return On Investment (TTM) 0.91 % 3.81 % 5.18 % 7.86 % 10.19 %
BMRN's Overall Ranking # 1762 # 1671 # 988 # 394 # 670
Seq. Investment Change TTM 13.24 % 4.75 % 1.71 % 2.64 % 3.08 %
Seq. Net Income Change TTM -72.85 % -22.97 % -32.96 % -20.82 % 25.46 %
Net Income (TTM) in Millions 73 269 349 520 657

BMRN Company Profile >> Back to BMRN Roi Comparisons >> See Annual BMRN Return On Investment



Return On Investment BMRN's Ranking
Within: No.
Industry # 61
Sector # 181
Overall # 1762

Return On Investment Statistics
High Average Low
21.79 %
-0.5 %
-18.95 %
(Mar 31 2011)   (Dec 31 2016)







Financial Statements
Biomarin Pharmaceutical Inc's II. Quarter Investments $ 10,508 Millions BMRN's Balance sheet
Biomarin Pharmaceutical Inc's II. Quarter Income $ 45 Millions Quarterly BMRN's Income Statement
BMRN's Income by Division See BMRN's Income by Division


BMRN Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 6,835 6,382 5,665 5,786 5,464
Y / Y Investment Growth 7.1 % 12.66 % -2.1 % 5.91 % 2.02 %
Net Income in Millions 349 427 168 142 -64
Y / Y Net Income Growth -18.26 % 154.62 % 18.43 % - -
Annual Return On Investment 5.1 % 6.69 % 2.96 % 2.45 % -1.17 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 5.1 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BMRN's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BMRN's Competitors
Subscribers only: Roi for Biomarin Pharmaceutical Inc's Suppliers
Subscribers only: Return On Investment for BMRN's Customers

Other Ratios
BMRN's Roa BMRN's Inventory Turnover Ratio BMRN's Growth Rates BMRN's Dividend Statistics
BMRN's Profitability Ratios BMRN's Asset Turnover Ratio BMRN's Dividend Growth
BMRN's Roe BMRN's Valuation Ratios BMRN's Financial Strength Ratios BMRN's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Mimedx Group Inc   2.38 %
Bio rad Laboratories Inc   2.34 %
Lifemd Inc   2.32 %
Alkermes Plc   2.31 %
Becton Dickinson And Company  2.22 %
Revvity Inc  2.18 %
Envista Holdings Corporation  2.06 %
Immucell Corporation  1.95 %
Atricure Inc   1.84 %
Black Hawk Acquisition Corporation  1.79 %
Omada Health Inc   1.70 %
Arvinas Inc   1.53 %
Repligen Corp  1.41 %
Cormedix Inc   1.31 %
Pacira Biosciences inc   1.29 %
Waters Corporation  1.20 %
Surgery Partners Inc   1.02 %
Warby Parker Inc   0.98 %
Staar Surgical Co  0.98 %
Biomarin Pharmaceutical Inc  0.91 %
Icu Medical Inc  0.87 %
Radnet Inc   0.45 %
Delcath Systems Inc   0.45 %

Date modified: 2026-09-12T06:12:52+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.